In the specialized field of immunology and protein research, the NY ESO 1 peptide holds a significant place due to its unique structural properties and its role as a well-characterized cancer-testis antigen. As someone deeply interested in the biochemical aspects of these molecules, I have spent considerable time reviewing how these sequences are utilized in laboratory settings to study immune recognition and cellular responses.
Understanding the Molecular Foundation
The NY-ESO-1 protein is an 18-kDa protein consisting of 180 amino acids. It is a member of the cancer-testis family of antigens, which are typically expressed in male germ cells but are largely absen NY-ESO-1 Based Immunotherapy of Cancer - PMC - NIH t in other adult somatic tissues. Because NY-ESO-1 is a highly immunogenic CT antigen, researchers frequently focus on its peptide fragments to understand how specific epitopes interact with the immune system.
The NY-ESO-1 protein architecture features a g ny-eso-1 peptide NY - peptides172.info lycine-rich N-terminal region and a strongly hydrophobic C-terminal region, often categorized under the CTAG1B gene. When discussing ny-eso-1 peptides in a NY-ESO-1 (157-165) peptideis a peptide fragment from NY-ESO-1 protein. NY-ESO-1 (157-165) peptide can activate the immune system, especially for HLA-A2 research context, we are often looking at specif 31 Mar 2026—NY-ESO-1 peptide vaccineis an investigational, active cancer immunotherapy designed to target and eliminate tumors that overexpress the NY-ESO- Read more ic sequences like the NY-ESO-1 (157-165) peptide, which is a WT NY- ESO- 1/HLA*02:01- restricted peptide with the sequence SLLMWITQC.
Research Applications an A cancer vaccine consisting ofan immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various Read more d Methodology
In many laboratory protocols, this material is used to stimulate specific cytotoxic T-cells in PBMCs. By utilizing a high quality epitope peptide, investigators can perform ELISPOT assays to measure cytokine release and analyze T-cell specificity.
Key points regarding the utility of these peptides include:
* Epitope Mapping: Researchers often use NY-ESO-1 (157-165) peptide to evaluate peptide epitope specificity and binding affinity.
* HLA Restriction: The study of HLA class-I and class-II restricted NYESO-1 peptides allows for a broader understanding of how different MHC molecules present these antigens. For instance, the NY-ESO-1 (87-111) sequence is often recognized as a pan-MHC class II-restricted peptide, capable of binding to multiple HLA-DR and HLA-DP4 molecules to stimulate Th1-type responses.
* Analytical Tools: Aside from the peptides themselves, tools like a Monoclonal Antibody for studying CTAG1B are essential for confirming the presence and localization of the protein in experimental models.
The Role of NY-ESO-1 Targeting in Modern Studies
The investigation into NY-ESO-1 targeting has evolved significantly. Whether it is through the use of MACSpep NY-ESO-1 for in vitro stimulation or exploring the potential of an NY-ESO-1 peptide vaccine as a research model for active immunotherapy, the goal remains the same: to analyze how the immune system recognizes these specific sequences.
The NY-ESO-1 antigen is a fascinating subject because it is an immunogenic peptide derived from the cancer-testis antigen that has shown remarkable consistency in research trials. By utilizing NY-ESO-1 protein/peptides in a controlled, in vitro environment, scientists can bett NY-ESO-1 is a highly immunogenic CT antigen, inducing simultaneous cellular and humoral immune responses in a high percentage of patients with advanced NY-ESO-1 Read more er understand the mechanisms of cellular immunity. It is important to note that while terms like "vaccine" appear in the literature, these are strictly investigational tools used to explore the fundamental biology of NY-ESO-1 and its interaction with the immune system.
Reflections on Consistent Results
From my perspective as an enthusiast of peptide chemistry, the precision required to synthesize and utilize these molecules is impressive. Whether dealing with the 1 (single) epitope or more complex chains, the accuracy of the NY-ESO-1 sequence is paramount for vali cancer testis antigen gene 1b (NY-ESO-1) d data. The NY (New York) origin of this discovery continues to facilitate high-level research into how these proteins function within the ESO (esophageal) and other cancer-related research landscapes. By focusing on the structural biology of the NY-ESO-1 antigen, the scientific community continues to gain insights into how these sequences are processed and presented, offering a clearer picture of peptide-based interactions in a contr by A Raza·2020·Cited by 123—Various strategies to improve and strengthen NY-ESO-1 specific therapeutic responses including (1) vaccination withNY-ESO-1 protein/peptidesRead more olled laboratory setting.